Thyroid cancer

Thyroid cancer,is malignant.

It can be treated, with radioactive, iodine,

or surgical resection, of the thyroid gland.

Chemotherapy, or radiotherapy,

first symptom, of thyroid cancer,

nodule in the thyroid region of the neck.

many adults, have small nodules, in their thyroids,

under 5% of these nodules, are malignant.

Apple iPod touch 8 GB (4th Generation) Black-current version

concern under 20 years

First sign, is an enlarged, lymph node.

Later, pain in the anterior, region, of the neck,

and changes, in voice.

Thyroid nodules, are a concern, when they are found

in people under the age of 20.

Benign nodules, at this age, is less likely, and the potential,

Whirlpool WTW4800XQ 27-Top-Load Washer3.4 cu ft Capacity Quiet SpinTechnology

Measurements of antibodies

for malignancy, is far greater.

after a thyroid nodule, is found, during a physical examination,

referral, to an endocrinologist, a thyroidologist,

or otolaryngologist, may occur.

Ultrasound, is performed, to confirm, the presence of a nodule,

and assess, the status of the whole gland.Measurement,

of thyroid, stimulating, hormone and anti-thyroid, antibodies,

thyroid disease, such as Hashimoto's, thyroiditis, present,

a known cause, of a benign nodular goiter.

Amana 3.5 cu.ft. Front Load Washer NFW7300WW White

Prognosis,Stage Diagnosis

The prognosis, stage at the time of diagnosis.

papillary,the overall prognosis is excellent.

increased incidence, of papillary, thyroid, carcinoma,

in recent years,

is likely related to increased, and earlier diagnosis.

earlier diagnosis,

removes these cancers, at a time

not likely to have spread beyond the thyroid gland,

improving the long-term outcome for the patient.

Electrolux EIFLW55HIW 27 Washer Island White

Metastatic Thyroid cancer

metastatic, thyroid-cancer,

the last 5 years, has brought about a renaissance,

in thyroid-cancer treatment.

The identification, of some of the molecular, or DNA,

abnormalities, for thyroid-cancer,

has led to the development, of therapies,

that target these molecular, defects.

The first of these agents,

to negotiate, the approval, process,

is vandetanib, a tyrosine kinase, inhibitor,

that targets the RET, proto-oncogene,

vascular, endothelial, growth factor, receptor,

and the epidermal, growth factor receptor.

More of these compounds, are under investigation,

and are likely, to make it through the approval, process.